CVS Health Co. (NYSE:CVS) Shares Sold by AMG National Trust Bank

AMG National Trust Bank lessened its stake in CVS Health Co. (NYSE:CVS - Free Report) by 12.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 99,858 shares of the pharmacy operator's stock after selling 14,117 shares during the period. AMG National Trust Bank's holdings in CVS Health were worth $4,404,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in CVS. MidAtlantic Capital Management Inc. acquired a new position in CVS Health in the 3rd quarter worth about $25,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health during the 3rd quarter worth approximately $31,000. Ridgewood Investments LLC lifted its position in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after buying an additional 450 shares in the last quarter. Stonebridge Financial Group LLC acquired a new stake in CVS Health in the 4th quarter valued at $28,000. Finally, RPg Family Wealth Advisory LLC purchased a new stake in CVS Health in the 3rd quarter worth $40,000. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Stock Down 0.1 %

NYSE:CVS traded down $0.07 during mid-day trading on Monday, hitting $66.26. The stock had a trading volume of 2,443,682 shares, compared to its average volume of 11,749,314. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a market capitalization of $83.54 billion, a PE ratio of 18.08, a PEG ratio of 0.98 and a beta of 0.54. The stock has a 50-day simple moving average of $56.42 and a two-hundred day simple moving average of $56.73.

Remove Ads

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, equities research analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.01%. The ex-dividend date was Thursday, January 23rd. CVS Health's dividend payout ratio (DPR) is 72.68%.

Insider Buying and Selling at CVS Health

In other CVS Health news, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the transaction, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Michael F. Mahoney bought 30,000 shares of CVS Health stock in a transaction dated Tuesday, February 18th. The stock was purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their position. The disclosure for this purchase can be found here. 0.24% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on CVS shares. JPMorgan Chase & Co. lifted their target price on shares of CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research report on Tuesday, February 18th. Wolfe Research boosted their price objective on CVS Health from 67.00 to 70.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 11th. Argus set a $77.00 price target on shares of CVS Health in a research note on Tuesday, February 18th. Edward Jones raised CVS Health from a "hold" rating to a "buy" rating in a research note on Thursday, January 30th. Finally, UBS Group reduced their price target on shares of CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 11th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $69.83.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.